Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|June 17, 2020
Age-associated genes in human mammary gland drive human breast cancer progressionXiang Gu, Bingzhi Wang, Haiyan Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignanciesJun S Wei, Peter Johansson, Qing-Rong Chen, et al.
Cancer Research|November 25, 2003
Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapyKacper Jankowski, Magda Kucia, Marcin Wysoczynski, et al.
Pediatric Blood & Cancer|October 17, 2022
Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcomaDouglas Harrison, Jonathan Gill, Michael Roth, et al.
Oncotarget|July 18, 2020
Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathwayAshley VanCleave, Mykayla Palmer, Fang Fang, et al.
Molecular Cancer Research : MCR|April 26, 2013
Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapyGabriela Schneider, Ewa Bryndza, Ahmed Abdel-Latif, et al.
Pediatric Blood & Cancer|June 14, 2012
The application of radiation therapy to the Pediatric Preclinical Testing Program (PPTP): results of a pilot study in rhabdomyosarcomaRita Kaplon, Mersiha Hadziahmetovic, Jim Sommerfeld, et al.
Investigational New Drugs|February 23, 2011
Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in miceGrace-Ifeyinwa Onimoe, Aiguo Liu, Li Lin, et al.
Pediatric Blood & Cancer|July 25, 2020
Dose-response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortiumJonathan Gill, Wendong Zhang, Zhongting Zhang, et al.
Oncoscience|January 17, 2015
Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitorGeorgia A McCann, Shan Naidu, Kellie S Rath, et al.
Pageof 6